These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 32572548)
21. Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. Brozic P; Lanisnik Risner T; Gobec S Curr Med Chem; 2008; 15(2):137-50. PubMed ID: 18220769 [TBL] [Abstract][Full Text] [Related]
22. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis. Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125 [TBL] [Abstract][Full Text] [Related]
23. Progestins and breast cancer. Pasqualini JR Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537 [TBL] [Abstract][Full Text] [Related]
24. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. Chetrite GS; Cortes-Prieto J; Philippe JC; Wright F; Pasqualini JR J Steroid Biochem Mol Biol; 2000; 72(1-2):23-7. PubMed ID: 10731634 [TBL] [Abstract][Full Text] [Related]
25. Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer. Wang X; Gérard C; Thériault JF; Poirier D; Doillon CJ; Lin SX J Mol Cell Biol; 2015 Dec; 7(6):568-79. PubMed ID: 25966904 [TBL] [Abstract][Full Text] [Related]
26. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures. Santner SJ; Ohlsson-Wilhelm B; Santen RJ Int J Cancer; 1993 Apr; 54(1):119-24. PubMed ID: 8478138 [TBL] [Abstract][Full Text] [Related]
27. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. Santner SJ; Feil PD; Santen RJ J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522 [TBL] [Abstract][Full Text] [Related]
28. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12). Fournier MA; Poirier D Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841 [TBL] [Abstract][Full Text] [Related]
29. Estrogen production and action. Nelson LR; Bulun SE J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861 [TBL] [Abstract][Full Text] [Related]
30. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism. Brueggemeier RW; Gu X; Mobley JA; Joomprabutra S; Bhat AS; Whetstone JL Ann N Y Acad Sci; 2001 Dec; 948():51-66. PubMed ID: 11795395 [TBL] [Abstract][Full Text] [Related]
31. Importance of estrogen sulfates in breast cancer. Pasqualini JR; Gelly C; Nguyen BL; Vella C J Steroid Biochem; 1989; 34(1-6):155-63. PubMed ID: 2560511 [TBL] [Abstract][Full Text] [Related]
32. 17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer. Jansson A J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):64-7. PubMed ID: 19167496 [TBL] [Abstract][Full Text] [Related]
33. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone. Laplante Y; Cadot C; Fournier MA; Poirier D Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543 [TBL] [Abstract][Full Text] [Related]
34. Loss of estrogen inactivation in colonic cancer. English MA; Kane KF; Cruickshank N; Langman MJ; Stewart PM; Hewison M J Clin Endocrinol Metab; 1999 Jun; 84(6):2080-5. PubMed ID: 10372714 [TBL] [Abstract][Full Text] [Related]
35. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity. Chetrite GS; Thole HH; Philippe JC; Pasqualini JR Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306 [TBL] [Abstract][Full Text] [Related]
36. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. Yue W; Santen RJ; Wang JP; Li Y; Verderame MF; Bocchinfuso WP; Korach KS; Devanesan P; Todorovic R; Rogan EG; Cavalieri EL J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):477-86. PubMed ID: 14623547 [TBL] [Abstract][Full Text] [Related]
37. Estrogen metabolism as a regulator of estrogen action in the mammary gland. Miettinen M; Isomaa V; Peltoketo H; Ghosh D; Vihko P J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):259-70. PubMed ID: 14973388 [TBL] [Abstract][Full Text] [Related]
38. Estrogen Metabolism in Abdominal Subcutaneous and Visceral Adipose Tissue in Postmenopausal Women. Hetemäki N; Savolainen-Peltonen H; Tikkanen MJ; Wang F; Paatela H; Hämäläinen E; Turpeinen U; Haanpää M; Vihma V; Mikkola TS J Clin Endocrinol Metab; 2017 Dec; 102(12):4588-4595. PubMed ID: 29029113 [TBL] [Abstract][Full Text] [Related]
39. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells. van de Ven J; Donker GH; Sprong M; Blankenstein MA; Thijssen JH J Steroid Biochem Mol Biol; 2002 Jul; 81(3):237-47. PubMed ID: 12163135 [TBL] [Abstract][Full Text] [Related]
40. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]